Association of adverse childhood experiences and neurodevelopmental disorders in people with fetal alcohol spectrum disorders (FASD) and non-FASD controls

Fetal alcohol spectrum disorder (FASD) is a highly prevalent lifelong disorder with high rates of comorbid neurodevelopmental disorders. Individuals with FASD are often exposed to abuse, neglect and foster home placements which have uncertain effects on the lifelong course of FASD. In this study we...

Full description

Saved in:
Bibliographic Details
Published inBMC pediatrics Vol. 19; no. 1; pp. 498 - 9
Main Authors Kambeitz, Cassondra, Klug, Marilyn G., Greenmyer, Jacob, Popova, Svetlana, Burd, Larry
Format Journal Article
LanguageEnglish
Published England BioMed Central Ltd 16.12.2019
BioMed Central
BMC
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Fetal alcohol spectrum disorder (FASD) is a highly prevalent lifelong disorder with high rates of comorbid neurodevelopmental disorders. Individuals with FASD are often exposed to abuse, neglect and foster home placements which have uncertain effects on the lifelong course of FASD. In this study we compare the prevalence of adverse childhood events (ACEs) and neurodevelopmental disorders in subjects with fetal alcohol spectrum disorders (FASD) and non-FASD controls. A cross-sectional chart review of patients referred to a regional developmental center was used to identify people with FASD and non-FASD controls. We recorded the number of ACEs and neurodevelopmental disorders in each patient's chart. The most common diagnoses were attention deficit hyperactivity disorder, comprehension deficits, sleep disorders, and cognitive impairments. T-tests and a regression equation were utilized to determine significant differences between the groups. The review identified 203 subjects, 98 with FASD and 105 non-FASD controls. Group mean age was 8.6 years and 64.5% were male. People with FASD were more likely to have any ACEs (mean 5.3) with ACE scores 3.7 points higher than non-FASD controls (mean 1.69) (t = 11.29; p < .001). Increased ACEs were associated with increased rates of neurodevelopmental disorders for people with FASD (R = .179, p = .026) but not for non-FASD controls (R = .130, p = .094). Both FASD and subsequent exposure to ACEs are associated with increased risk for development of comorbid neurodevelopmental disorders. Prevention of ACEs during childhood may decrease risk for development of comorbid neurodevelopmental disorders.
AbstractList Fetal alcohol spectrum disorder (FASD) is a highly prevalent lifelong disorder with high rates of comorbid neurodevelopmental disorders. Individuals with FASD are often exposed to abuse, neglect and foster home placements which have uncertain effects on the lifelong course of FASD. In this study we compare the prevalence of adverse childhood events (ACEs) and neurodevelopmental disorders in subjects with fetal alcohol spectrum disorders (FASD) and non-FASD controls.BACKGROUNDFetal alcohol spectrum disorder (FASD) is a highly prevalent lifelong disorder with high rates of comorbid neurodevelopmental disorders. Individuals with FASD are often exposed to abuse, neglect and foster home placements which have uncertain effects on the lifelong course of FASD. In this study we compare the prevalence of adverse childhood events (ACEs) and neurodevelopmental disorders in subjects with fetal alcohol spectrum disorders (FASD) and non-FASD controls.A cross-sectional chart review of patients referred to a regional developmental center was used to identify people with FASD and non-FASD controls. We recorded the number of ACEs and neurodevelopmental disorders in each patient's chart. The most common diagnoses were attention deficit hyperactivity disorder, comprehension deficits, sleep disorders, and cognitive impairments. T-tests and a regression equation were utilized to determine significant differences between the groups.METHODSA cross-sectional chart review of patients referred to a regional developmental center was used to identify people with FASD and non-FASD controls. We recorded the number of ACEs and neurodevelopmental disorders in each patient's chart. The most common diagnoses were attention deficit hyperactivity disorder, comprehension deficits, sleep disorders, and cognitive impairments. T-tests and a regression equation were utilized to determine significant differences between the groups.The review identified 203 subjects, 98 with FASD and 105 non-FASD controls. Group mean age was 8.6 years and 64.5% were male. People with FASD were more likely to have any ACEs (mean 5.3) with ACE scores 3.7 points higher than non-FASD controls (mean 1.69) (t = 11.29; p < .001). Increased ACEs were associated with increased rates of neurodevelopmental disorders for people with FASD (R = .179, p = .026) but not for non-FASD controls (R = .130, p = .094).RESULTSThe review identified 203 subjects, 98 with FASD and 105 non-FASD controls. Group mean age was 8.6 years and 64.5% were male. People with FASD were more likely to have any ACEs (mean 5.3) with ACE scores 3.7 points higher than non-FASD controls (mean 1.69) (t = 11.29; p < .001). Increased ACEs were associated with increased rates of neurodevelopmental disorders for people with FASD (R = .179, p = .026) but not for non-FASD controls (R = .130, p = .094).Both FASD and subsequent exposure to ACEs are associated with increased risk for development of comorbid neurodevelopmental disorders. Prevention of ACEs during childhood may decrease risk for development of comorbid neurodevelopmental disorders.CONCLUSIONSBoth FASD and subsequent exposure to ACEs are associated with increased risk for development of comorbid neurodevelopmental disorders. Prevention of ACEs during childhood may decrease risk for development of comorbid neurodevelopmental disorders.
Fetal alcohol spectrum disorder (FASD) is a highly prevalent lifelong disorder with high rates of comorbid neurodevelopmental disorders. Individuals with FASD are often exposed to abuse, neglect and foster home placements which have uncertain effects on the lifelong course of FASD. In this study we compare the prevalence of adverse childhood events (ACEs) and neurodevelopmental disorders in subjects with fetal alcohol spectrum disorders (FASD) and non-FASD controls. A cross-sectional chart review of patients referred to a regional developmental center was used to identify people with FASD and non-FASD controls. We recorded the number of ACEs and neurodevelopmental disorders in each patient's chart. The most common diagnoses were attention deficit hyperactivity disorder, comprehension deficits, sleep disorders, and cognitive impairments. T-tests and a regression equation were utilized to determine significant differences between the groups. The review identified 203 subjects, 98 with FASD and 105 non-FASD controls. Group mean age was 8.6 years and 64.5% were male. People with FASD were more likely to have any ACEs (mean 5.3) with ACE scores 3.7 points higher than non-FASD controls (mean 1.69) (t = 11.29; p < .001). Increased ACEs were associated with increased rates of neurodevelopmental disorders for people with FASD (R = .179, p = .026) but not for non-FASD controls (R = .130, p = .094). Both FASD and subsequent exposure to ACEs are associated with increased risk for development of comorbid neurodevelopmental disorders. Prevention of ACEs during childhood may decrease risk for development of comorbid neurodevelopmental disorders.
Background Fetal alcohol spectrum disorder (FASD) is a highly prevalent lifelong disorder with high rates of comorbid neurodevelopmental disorders. Individuals with FASD are often exposed to abuse, neglect and foster home placements which have uncertain effects on the lifelong course of FASD. In this study we compare the prevalence of adverse childhood events (ACEs) and neurodevelopmental disorders in subjects with fetal alcohol spectrum disorders (FASD) and non-FASD controls. Methods A cross-sectional chart review of patients referred to a regional developmental center was used to identify people with FASD and non-FASD controls. We recorded the number of ACEs and neurodevelopmental disorders in each patient's chart. The most common diagnoses were attention deficit hyperactivity disorder, comprehension deficits, sleep disorders, and cognitive impairments. T-tests and a regression equation were utilized to determine significant differences between the groups. Results The review identified 203 subjects, 98 with FASD and 105 non-FASD controls. Group mean age was 8.6 years and 64.5% were male. People with FASD were more likely to have any ACEs (mean 5.3) with ACE scores 3.7 points higher than non-FASD controls (mean 1.69) (t = 11.29; p < .001). Increased ACEs were associated with increased rates of neurodevelopmental disorders for people with FASD (R = .179, p = .026) but not for non-FASD controls (R = .130, p = .094). Conclusions: Both FASD and subsequent exposure to ACEs are associated with increased risk for development of comorbid neurodevelopmental disorders. Prevention of ACEs during childhood may decrease risk for development of comorbid neurodevelopmental disorders. Keywords: Children, Adverse childhood experiences, Fetal alcohol spectrum disorders, Comorbidity, Child protection, Criminal justice, Special education, Outcomes, Controls
Fetal alcohol spectrum disorder (FASD) is a highly prevalent lifelong disorder with high rates of comorbid neurodevelopmental disorders. Individuals with FASD are often exposed to abuse, neglect and foster home placements which have uncertain effects on the lifelong course of FASD. In this study we compare the prevalence of adverse childhood events (ACEs) and neurodevelopmental disorders in subjects with fetal alcohol spectrum disorders (FASD) and non-FASD controls. A cross-sectional chart review of patients referred to a regional developmental center was used to identify people with FASD and non-FASD controls. We recorded the number of ACEs and neurodevelopmental disorders in each patient's chart. The most common diagnoses were attention deficit hyperactivity disorder, comprehension deficits, sleep disorders, and cognitive impairments. T-tests and a regression equation were utilized to determine significant differences between the groups. The review identified 203 subjects, 98 with FASD and 105 non-FASD controls. Group mean age was 8.6 years and 64.5% were male. People with FASD were more likely to have any ACEs (mean 5.3) with ACE scores 3.7 points higher than non-FASD controls (mean 1.69) (t = 11.29; p < .001). Increased ACEs were associated with increased rates of neurodevelopmental disorders for people with FASD (R = .179, p = .026) but not for non-FASD controls (R = .130, p = .094).
Background Fetal alcohol spectrum disorder (FASD) is a highly prevalent lifelong disorder with high rates of comorbid neurodevelopmental disorders. Individuals with FASD are often exposed to abuse, neglect and foster home placements which have uncertain effects on the lifelong course of FASD. In this study we compare the prevalence of adverse childhood events (ACEs) and neurodevelopmental disorders in subjects with fetal alcohol spectrum disorders (FASD) and non-FASD controls. Methods A cross-sectional chart review of patients referred to a regional developmental center was used to identify people with FASD and non-FASD controls. We recorded the number of ACEs and neurodevelopmental disorders in each patient’s chart. The most common diagnoses were attention deficit hyperactivity disorder, comprehension deficits, sleep disorders, and cognitive impairments. T-tests and a regression equation were utilized to determine significant differences between the groups. Results The review identified 203 subjects, 98 with FASD and 105 non-FASD controls. Group mean age was 8.6 years and 64.5% were male. People with FASD were more likely to have any ACEs (mean 5.3) with ACE scores 3.7 points higher than non-FASD controls (mean 1.69) (t = 11.29; p < .001). Increased ACEs were associated with increased rates of neurodevelopmental disorders for people with FASD (R = .179, p = .026) but not for non-FASD controls (R = .130, p = .094). Conclusions: Both FASD and subsequent exposure to ACEs are associated with increased risk for development of comorbid neurodevelopmental disorders. Prevention of ACEs during childhood may decrease risk for development of comorbid neurodevelopmental disorders.
Abstract Background Fetal alcohol spectrum disorder (FASD) is a highly prevalent lifelong disorder with high rates of comorbid neurodevelopmental disorders. Individuals with FASD are often exposed to abuse, neglect and foster home placements which have uncertain effects on the lifelong course of FASD. In this study we compare the prevalence of adverse childhood events (ACEs) and neurodevelopmental disorders in subjects with fetal alcohol spectrum disorders (FASD) and non-FASD controls. Methods A cross-sectional chart review of patients referred to a regional developmental center was used to identify people with FASD and non-FASD controls. We recorded the number of ACEs and neurodevelopmental disorders in each patient’s chart. The most common diagnoses were attention deficit hyperactivity disorder, comprehension deficits, sleep disorders, and cognitive impairments. T-tests and a regression equation were utilized to determine significant differences between the groups. Results The review identified 203 subjects, 98 with FASD and 105 non-FASD controls. Group mean age was 8.6 years and 64.5% were male. People with FASD were more likely to have any ACEs (mean 5.3) with ACE scores 3.7 points higher than non-FASD controls (mean 1.69) (t = 11.29; p < .001). Increased ACEs were associated with increased rates of neurodevelopmental disorders for people with FASD (R = .179, p = .026) but not for non-FASD controls (R = .130, p = .094). Conclusions: Both FASD and subsequent exposure to ACEs are associated with increased risk for development of comorbid neurodevelopmental disorders. Prevention of ACEs during childhood may decrease risk for development of comorbid neurodevelopmental disorders.
ArticleNumber 498
Audience Academic
Author Kambeitz, Cassondra
Popova, Svetlana
Klug, Marilyn G.
Greenmyer, Jacob
Burd, Larry
Author_xml – sequence: 1
  givenname: Cassondra
  surname: Kambeitz
  fullname: Kambeitz, Cassondra
– sequence: 2
  givenname: Marilyn G.
  surname: Klug
  fullname: Klug, Marilyn G.
– sequence: 3
  givenname: Jacob
  surname: Greenmyer
  fullname: Greenmyer, Jacob
– sequence: 4
  givenname: Svetlana
  surname: Popova
  fullname: Popova, Svetlana
– sequence: 5
  givenname: Larry
  orcidid: 0000-0001-7199-2711
  surname: Burd
  fullname: Burd, Larry
BackLink https://www.ncbi.nlm.nih.gov/pubmed/31842817$$D View this record in MEDLINE/PubMed
BookMark eNp1kstu1DAYhSNURC_wAGxQJCRUFil2nPiyQRoVCpUqsQDWlmP_aVx57GAnA7wKT4vTaWGmAnnh23eO7d_nuDjwwUNRPMfoDGNO3yRcc84qhEWFOeMVf1Qc4Ybhqm4IPtgZHxbHKd0ghBlv6JPikGDe1Byzo-LXKqWgrZps8GXoS2U2EBOUerDODCGYEn6MEC14DalU3pQe5hgMbMCFcQ1-Uq40NoVosq60vhwhjA7K73Yayh6WbeV0GIIr0wh6ivN6hz-9WH1-93rrG3y1zEod_BSDS0-Lx71yCZ7d9SfF14v3X84_VlefPlyer64q3Qo8VQppVTMFhNeo7SnrkCCCaCpqjohhuu46ihtaC9x3WBhMWmJI3YNWQBngjpwUl1tfE9SNHKNdq_hTBmXl7UKI11LFyWoHsqVE6Jox3DSsMQ0Wohc9pZ1Bfcs0NNnr7dZrnLs1GJ3rE5XbM93f8XaQ12EjqcC1aGg2OL0ziOHbDGmSa5s0OKc8hDnJmtRMkLbNjzwpXj5Ab8IcfS7VQvEWZ4r-pa5VfoD1fcjn6sVUrihGBAlGUabO_kHlZmBt84dAb_P6nuDVjmAA5aYhBTcvOUr74IvdivwpxX0EM8C2gI4hpQi91Ha6zWO-gnUSI7mEXW7DLnPY5RJ2ybMSP1Dem_9f8xsrlQC-
CitedBy_id crossref_primary_10_3389_fnint_2023_1104788
crossref_primary_10_1016_j_pediatrneurol_2024_04_023
crossref_primary_10_1097_AOG_0000000000004632
crossref_primary_10_1016_j_earlhumdev_2020_105119
crossref_primary_10_1080_19315864_2023_2285040
crossref_primary_10_1016_j_drugalcdep_2020_108412
crossref_primary_10_1016_j_ridd_2023_104481
crossref_primary_10_4236_ojped_2021_114054
crossref_primary_10_1016_j_yfrne_2023_101103
crossref_primary_10_1111_cch_12817
crossref_primary_10_3390_ijerph192315663
crossref_primary_10_1016_j_cpr_2022_102155
crossref_primary_10_1007_s11920_020_01193_w
crossref_primary_10_1016_S2352_4642_24_00331_6
crossref_primary_10_1007_s11469_021_00652_6
crossref_primary_10_1111_acer_70039
crossref_primary_10_1016_j_brainres_2020_147128
crossref_primary_10_3390_nu16111655
crossref_primary_10_1080_09297049_2021_2023122
crossref_primary_10_1016_j_ntt_2025_107436
crossref_primary_10_3390_ijerph20176706
crossref_primary_10_1007_s40474_021_00241_1
crossref_primary_10_1016_j_neuro_2021_08_013
crossref_primary_10_3389_fnbeh_2021_786234
crossref_primary_10_3389_fnins_2023_1182635
crossref_primary_10_1111_acer_15394
crossref_primary_10_3109_13668250_2025_2449677
crossref_primary_10_1111_acer_15191
crossref_primary_10_1177_14550725221110190
crossref_primary_10_3390_ijerph16203978
crossref_primary_10_1111_acer_14934
crossref_primary_10_3389_fnbeh_2025_1501937
crossref_primary_10_1016_j_chiabu_2023_106594
crossref_primary_10_3389_fnmol_2021_671891
crossref_primary_10_1016_S2352_4642_24_00188_3
crossref_primary_10_1177_0040059920977887
crossref_primary_10_3389_adar_2023_10877
crossref_primary_10_1080_13218719_2022_2059028
crossref_primary_10_3389_fped_2023_1146149
crossref_primary_10_1016_j_childyouth_2023_107192
crossref_primary_10_1002_bsl_2540
crossref_primary_10_1016_j_fsiml_2022_100109
crossref_primary_10_3390_disabilities4020022
crossref_primary_10_3390_jcm13061627
crossref_primary_10_1007_s10989_021_10173_4
crossref_primary_10_3389_fpsyg_2021_778471
crossref_primary_10_1016_j_ridd_2023_104479
crossref_primary_10_1186_s12887_022_03654_y
crossref_primary_10_3390_healthcare10010084
crossref_primary_10_1016_j_ridd_2023_104553
crossref_primary_10_1080_14999013_2020_1852342
crossref_primary_10_3390_ijerph19137744
crossref_primary_10_1016_j_childyouth_2023_107239
crossref_primary_10_23736_S2724_5276_24_07365_8
crossref_primary_10_1038_s41598_022_26590_4
crossref_primary_10_1111_acer_14761
crossref_primary_10_1111_acer_15212
crossref_primary_10_1038_s41572_023_00420_x
crossref_primary_10_1016_j_chiabu_2020_104888
crossref_primary_10_1016_j_ssmph_2020_100625
crossref_primary_10_1111_acer_15010
crossref_primary_10_1111_1460_6984_12644
crossref_primary_10_3390_children11010005
Cites_doi 10.1016/j.ijlp.2017.12.008
10.1097/ADM.0000000000000438
10.1016/S0091-7435(03)00123-3
10.1097/DBP.0000000000000440
10.1080/19315864.2014.930549
10.1111/acer.13032
10.1176/appi.books.9780890425596
10.1542/peds.2015-4268L
10.1016/S0140-6736(15)01346-X
10.1016/j.alcohol.2009.08.010
10.1111/dmcn.12029
10.1016/j.amepre.2007.01.005
10.1016/j.whi.2015.06.007
10.1542/peds.2014-2171
10.1016/j.ntt.2003.07.014
10.1542/peds.2013-0066
10.1053/scnp.2000.6729
10.1016/S0749-3797(98)00017-8
10.1111/add.14598
10.1016/j.ntt.2003.07.015
10.15585/mmwr.mm6437a3
10.1503/cmaj.141593
10.1542/peds.108.2.e34
10.2174/1573404813666170418114243
10.1080/13556210410001717088
10.4236/ojped.2014.41003
10.1097/PSY.0b013e3181907888
10.3109/09638237.2011.577113
10.1016/j.drugalcdep.2015.08.006
10.1097/DBP.0000000000000523
10.1016/S0140-6736(15)01345-8
10.1515/IJDHD.2007.6.4.383
10.1002/ddrr.74
10.1007/978-1-4757-5217-5
10.1080/21622965.2013.877392
10.1080/23311908.2016.1214213
10.7895/ijadr.v2i3.173
10.1016/j.alcohol.2018.06.002
ContentType Journal Article
Copyright COPYRIGHT 2019 BioMed Central Ltd.
2019. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
The Author(s). 2019
Copyright_xml – notice: COPYRIGHT 2019 BioMed Central Ltd.
– notice: 2019. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
– notice: The Author(s). 2019
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7X7
7XB
88E
8FI
8FJ
8FK
ABUWG
AFKRA
AZQEC
BENPR
CCPQU
DWQXO
FYUFA
GHDGH
K9.
M0S
M1P
PHGZM
PHGZT
PIMPY
PJZUB
PKEHL
PPXIY
PQEST
PQQKQ
PQUKI
PRINS
7X8
5PM
DOA
DOI 10.1186/s12887-019-1878-8
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
ProQuest Central (Corporate)
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
ProQuest Hospital Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central Essentials
ProQuest Central
ProQuest One Community College
ProQuest Central
Health Research Premium Collection (UHCL Subscription)
Health Research Premium Collection (Alumni)
ProQuest Health & Medical Complete (Alumni)
Health & Medical Collection (Alumni)
Medical Database
ProQuest Central Premium
ProQuest One Academic
Publicly Available Content Database
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
MEDLINE - Academic
PubMed Central (Full Participant titles)
Directory of Open Access Journals (DOAJ)
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Publicly Available Content Database
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Central China
ProQuest Central
ProQuest Health & Medical Research Collection
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
ProQuest Central Korea
Health & Medical Research Collection
ProQuest Central (New)
ProQuest Medical Library (Alumni)
ProQuest One Academic Eastern Edition
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
ProQuest Hospital Collection (Alumni)
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest One Academic UKI Edition
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic
MEDLINE



Publicly Available Content Database

Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 4
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1471-2431
EndPage 9
ExternalDocumentID oai_doaj_org_article_5639c27714474d4199f9f66bd0f57ce4
PMC6912946
A610309760
31842817
10_1186_s12887_019_1878_8
Genre Journal Article
GeographicLocations United States--US
GeographicLocations_xml – name: United States--US
GroupedDBID ---
0R~
23N
2WC
53G
5VS
6J9
6PF
7X7
88E
8FI
8FJ
AAFWJ
AAJSJ
AASML
AAWTL
AAYXX
ABUWG
ACGFO
ACGFS
ACIHN
ADBBV
ADRAZ
ADUKV
AEAQA
AENEX
AFKRA
AFPKN
AHBYD
AHMBA
AHYZX
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AMKLP
AMTXH
AOIJS
BAPOH
BAWUL
BCNDV
BENPR
BFQNJ
BMC
BPHCQ
BVXVI
C6C
CCPQU
CITATION
CS3
DIK
DU5
E3Z
EBD
EBLON
EBS
EJD
EMB
EMOBN
F5P
FYUFA
GROUPED_DOAJ
GX1
H13
HMCUK
HYE
IAO
IHR
IHW
INH
INR
ITC
KQ8
M1P
M48
M~E
O5R
O5S
OK1
OVT
P2P
PGMZT
PHGZM
PHGZT
PIMPY
PQQKQ
PROAC
PSQYO
RBZ
RNS
ROL
RPM
RSV
SMD
SOJ
SV3
TR2
UKHRP
W2D
WOQ
WOW
XSB
CGR
CUY
CVF
ECM
EIF
NPM
PMFND
3V.
7XB
8FK
AZQEC
DWQXO
K9.
PJZUB
PKEHL
PPXIY
PQEST
PQUKI
PRINS
7X8
5PM
PUEGO
ID FETCH-LOGICAL-c591t-a0ca27ae38205f67b09393c692803d7c2bb6146291fb19d1353d32fecae67e1b3
IEDL.DBID M48
ISSN 1471-2431
IngestDate Wed Aug 27 01:31:03 EDT 2025
Thu Aug 21 13:38:06 EDT 2025
Mon Jul 21 11:52:58 EDT 2025
Fri Jul 25 22:57:22 EDT 2025
Tue Jun 17 21:46:32 EDT 2025
Tue Jun 10 20:50:01 EDT 2025
Thu May 22 21:22:20 EDT 2025
Thu Apr 03 07:04:44 EDT 2025
Thu Apr 24 23:11:51 EDT 2025
Tue Jul 01 01:20:07 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Keywords Child protection
Fetal alcohol spectrum disorders
Comorbidity
Criminal justice
Controls
Children
Adverse childhood experiences
Special education
Outcomes
Language English
License Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c591t-a0ca27ae38205f67b09393c692803d7c2bb6146291fb19d1353d32fecae67e1b3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ORCID 0000-0001-7199-2711
OpenAccessLink http://journals.scholarsportal.info/openUrl.xqy?doi=10.1186/s12887-019-1878-8
PMID 31842817
PQID 2328515506
PQPubID 42847
PageCount 9
ParticipantIDs doaj_primary_oai_doaj_org_article_5639c27714474d4199f9f66bd0f57ce4
pubmedcentral_primary_oai_pubmedcentral_nih_gov_6912946
proquest_miscellaneous_2327935509
proquest_journals_2328515506
gale_infotracmisc_A610309760
gale_infotracacademiconefile_A610309760
gale_healthsolutions_A610309760
pubmed_primary_31842817
crossref_citationtrail_10_1186_s12887_019_1878_8
crossref_primary_10_1186_s12887_019_1878_8
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2019-12-16
PublicationDateYYYYMMDD 2019-12-16
PublicationDate_xml – month: 12
  year: 2019
  text: 2019-12-16
  day: 16
PublicationDecade 2010
PublicationPlace England
PublicationPlace_xml – name: England
– name: London
PublicationTitle BMC pediatrics
PublicationTitleAlternate BMC Pediatr
PublicationYear 2019
Publisher BioMed Central Ltd
BioMed Central
BMC
Publisher_xml – name: BioMed Central Ltd
– name: BioMed Central
– name: BMC
References AP Streissguth (1878_CR3) 2000; 5
J Pei (1878_CR13) 2011; 20
L Burd (1878_CR36) 2003; 25
MJ O'Connor (1878_CR12) 2009; 15
VJ Felitti (1878_CR29) 1998; 14
JD Stinson (1878_CR18) 2014; 7
JA Martin (1878_CR8) 2015; 64
L Burd (1878_CR22) 2016; 387
K Flannigan (1878_CR21) 2018; 57
SR Dube (1878_CR42) 2003; 37
IJ Chasnoff (1878_CR9) 2015; 135
CH Tan (1878_CR1) 2015; 64
EL Abel (1878_CR45) 1998
PA May (1878_CR7) 2015; 155
L Burd (1878_CR11) 2007; 6
C O'Leary (1878_CR14) 2013; 55
JJ Boseck (1878_CR15) 2015; 4
1878_CR17
S Lange (1878_CR37) 2013; 132
L Burd (1878_CR38) 2003; 25
JL Cook (1878_CR6) 2016; 188
M Schwartz (1878_CR25) 2017; 13
JR Greenmyer (1878_CR26) 2018; 12
A Thompson (1878_CR23) 2014; 4
L Burd (1878_CR27) 2013; 2
RAS Mukherjee (1878_CR35) 2019; 76
DJ Frankenberger (1878_CR33) 2015; 25
L Burd (1878_CR39) 2010; 44
H Nathan (1878_CR19) 2016; 3
L Burd (1878_CR24) 2004; 9
K McLachlan (1878_CR34) 2015; 22
D Weyrauch (1878_CR16) 2017; 38
CD Coles (1878_CR44) 2016; 40
DM Holman (1878_CR31) 2016; 138
S Popova (1878_CR43) 2016; 387
L Burd (1878_CR28) 2016; 387
1878_CR41
SR Dube (1878_CR30) 2009; 71
1878_CR4
Sean Johnson (1878_CR40) 2018; 39
1878_CR5
RF Anda (1878_CR32) 2007; 32
1878_CR2
B Sood (1878_CR10) 2001; 108
1878_CR20
References_xml – volume: 57
  start-page: 42
  year: 2018
  ident: 1878_CR21
  publication-title: Int J Law Psychiatry
  doi: 10.1016/j.ijlp.2017.12.008
– volume: 12
  start-page: 466
  issue: 6
  year: 2018
  ident: 1878_CR26
  publication-title: J Addict Med
  doi: 10.1097/ADM.0000000000000438
– volume: 37
  start-page: 268
  issue: 3
  year: 2003
  ident: 1878_CR42
  publication-title: Prev Med
  doi: 10.1016/S0091-7435(03)00123-3
– volume: 38
  start-page: 283
  issue: 4
  year: 2017
  ident: 1878_CR16
  publication-title: J Dev Behav Pediatr
  doi: 10.1097/DBP.0000000000000440
– volume: 7
  start-page: 337
  issue: 4
  year: 2014
  ident: 1878_CR18
  publication-title: J Ment Health Res Intellect Disabil
  doi: 10.1080/19315864.2014.930549
– ident: 1878_CR4
– volume: 40
  start-page: 1000
  issue: 5
  year: 2016
  ident: 1878_CR44
  publication-title: Alcohol Clin Exp Res
  doi: 10.1111/acer.13032
– ident: 1878_CR5
  doi: 10.1176/appi.books.9780890425596
– volume: 64
  start-page: 1
  issue: 1
  year: 2015
  ident: 1878_CR8
  publication-title: Natl Vital Stat Rep
– ident: 1878_CR20
– volume: 138
  start-page: S81
  issue: Suppl 1
  year: 2016
  ident: 1878_CR31
  publication-title: Pediatr
  doi: 10.1542/peds.2015-4268L
– volume: 387
  start-page: 926
  issue: 10022
  year: 2016
  ident: 1878_CR28
  publication-title: Lancet
  doi: 10.1016/S0140-6736(15)01346-X
– volume: 44
  start-page: 605
  year: 2010
  ident: 1878_CR39
  publication-title: Alcohol
  doi: 10.1016/j.alcohol.2009.08.010
– volume: 55
  start-page: 271
  issue: 3
  year: 2013
  ident: 1878_CR14
  publication-title: Dev Med Child Neurol
  doi: 10.1111/dmcn.12029
– volume: 32
  start-page: 389
  issue: 5
  year: 2007
  ident: 1878_CR32
  publication-title: Am J Prev Med
  doi: 10.1016/j.amepre.2007.01.005
– volume: 25
  start-page: 688
  issue: 6
  year: 2015
  ident: 1878_CR33
  publication-title: Womens Health Issues
  doi: 10.1016/j.whi.2015.06.007
– volume: 135
  start-page: 264
  issue: 2
  year: 2015
  ident: 1878_CR9
  publication-title: Pediatr
  doi: 10.1542/peds.2014-2171
– volume: 387
  start-page: 926
  issue: 10022
  year: 2016
  ident: 1878_CR22
  publication-title: Lancet
  doi: 10.1016/S0140-6736(15)01346-X
– volume: 25
  start-page: 697
  issue: 6
  year: 2003
  ident: 1878_CR36
  publication-title: Neurotoxicol Teratol
  doi: 10.1016/j.ntt.2003.07.014
– volume: 132
  start-page: e980
  issue: 4
  year: 2013
  ident: 1878_CR37
  publication-title: Pediatr
  doi: 10.1542/peds.2013-0066
– volume: 5
  start-page: 177
  issue: 3
  year: 2000
  ident: 1878_CR3
  publication-title: Semin Clin Neuropsychiatry
  doi: 10.1053/scnp.2000.6729
– volume: 14
  start-page: 245
  issue: 4
  year: 1998
  ident: 1878_CR29
  publication-title: Am J Prev Med
  doi: 10.1016/S0749-3797(98)00017-8
– volume: 22
  start-page: e108
  issue: 1
  year: 2015
  ident: 1878_CR34
  publication-title: J Popul Ther Clin Pharmacol
– ident: 1878_CR17
  doi: 10.1111/add.14598
– volume: 25
  start-page: 719
  issue: 6
  year: 2003
  ident: 1878_CR38
  publication-title: Neurotoxicol Teratol
  doi: 10.1016/j.ntt.2003.07.015
– ident: 1878_CR41
– volume: 64
  start-page: 1042
  issue: 37
  year: 2015
  ident: 1878_CR1
  publication-title: MMWR Morb Mortal Wkly Rep
  doi: 10.15585/mmwr.mm6437a3
– volume: 188
  start-page: 191
  issue: 3
  year: 2016
  ident: 1878_CR6
  publication-title: CMAJ
  doi: 10.1503/cmaj.141593
– volume: 108
  start-page: E34
  issue: 2
  year: 2001
  ident: 1878_CR10
  publication-title: Pediatr
  doi: 10.1542/peds.108.2.e34
– volume: 13
  start-page: 96
  issue: 2
  year: 2017
  ident: 1878_CR25
  publication-title: Curr Womens Health Rev
  doi: 10.2174/1573404813666170418114243
– volume: 9
  start-page: 179
  issue: 2
  year: 2004
  ident: 1878_CR24
  publication-title: Addict Biol
  doi: 10.1080/13556210410001717088
– volume: 4
  start-page: 21
  year: 2014
  ident: 1878_CR23
  publication-title: Open J Pediatr
  doi: 10.4236/ojped.2014.41003
– volume: 71
  start-page: 243
  issue: 2
  year: 2009
  ident: 1878_CR30
  publication-title: Psychosom Med
  doi: 10.1097/PSY.0b013e3181907888
– volume: 20
  start-page: 438
  issue: 5
  year: 2011
  ident: 1878_CR13
  publication-title: J Ment Health
  doi: 10.3109/09638237.2011.577113
– ident: 1878_CR2
– volume: 155
  start-page: 118
  year: 2015
  ident: 1878_CR7
  publication-title: Drug Alcohol Depend
  doi: 10.1016/j.drugalcdep.2015.08.006
– volume: 39
  start-page: 163
  issue: 2
  year: 2018
  ident: 1878_CR40
  publication-title: Journal of Developmental & Behavioral Pediatrics
  doi: 10.1097/DBP.0000000000000523
– volume: 387
  start-page: 978
  issue: 10022
  year: 2016
  ident: 1878_CR43
  publication-title: Lancet
  doi: 10.1016/S0140-6736(15)01345-8
– volume: 6
  start-page: 383
  issue: 4
  year: 2007
  ident: 1878_CR11
  publication-title: Int J Disabil Hum Dev
  doi: 10.1515/IJDHD.2007.6.4.383
– volume: 15
  start-page: 225
  issue: 3
  year: 2009
  ident: 1878_CR12
  publication-title: Dev Disabil Res Rev
  doi: 10.1002/ddrr.74
– volume-title: Fetal alcohol abuse syndrome
  year: 1998
  ident: 1878_CR45
  doi: 10.1007/978-1-4757-5217-5
– volume: 4
  start-page: 230
  issue: 4
  year: 2015
  ident: 1878_CR15
  publication-title: Appl Neuropsychol Child
  doi: 10.1080/21622965.2013.877392
– volume: 3
  start-page: 1214213
  issue: 1
  year: 2016
  ident: 1878_CR19
  publication-title: Cogent Psychol
  doi: 10.1080/23311908.2016.1214213
– volume: 2
  start-page: 3
  issue: 3
  year: 2013
  ident: 1878_CR27
  publication-title: Int J Alcohol Drug Res
  doi: 10.7895/ijadr.v2i3.173
– volume: 76
  start-page: 23
  year: 2019
  ident: 1878_CR35
  publication-title: Alcohol
  doi: 10.1016/j.alcohol.2018.06.002
SSID ssj0017846
Score 2.4907143
Snippet Fetal alcohol spectrum disorder (FASD) is a highly prevalent lifelong disorder with high rates of comorbid neurodevelopmental disorders. Individuals with FASD...
Background Fetal alcohol spectrum disorder (FASD) is a highly prevalent lifelong disorder with high rates of comorbid neurodevelopmental disorders. Individuals...
Abstract Background Fetal alcohol spectrum disorder (FASD) is a highly prevalent lifelong disorder with high rates of comorbid neurodevelopmental disorders....
SourceID doaj
pubmedcentral
proquest
gale
pubmed
crossref
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Enrichment Source
StartPage 498
SubjectTerms Adolescent
Adverse childhood experiences
Adverse Childhood Experiences - statistics & numerical data
Alcohol use
Attention deficit hyperactivity disorder
Child
Child protection
Child, Preschool
Childhood
Children
Comorbidity
Criminal justice
Cross-Sectional Studies
Disabilities
Female
Fetal Alcohol Spectrum Disorders
Fetal alcohol syndrome
Humans
Hyperactivity
Male
Mental disorders
Neurodevelopmental disorders
Neurodevelopmental Disorders - epidemiology
Neurodevelopmental Disorders - etiology
Prevalence
Self Report
Sleep
Sleep disorders
Special education
Womens health
Young Adult
SummonAdditionalLinks – databaseName: Directory of Open Access Journals (DOAJ)
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1bi9UwEA6yD-KLuF6rq0YQvEDYpm2S5vF4OSyCvujCvoXcigvaI3b3z-yvdSbJqS2CvvhSOM30NjOZy8nkG0Ket3XjnBCKIbw361xnmdYuMEidXeu8b-CA1Raf5Mlp9-FMnC1afWFNWIYHzow7FuBCfaMUBP6qCx3XetCDlC7Ug1A-JiRQ8Hn7ZKqsHyhwq2UNk_fyeAIr3GOJpWa8h7SpX3mhBNb_p0le-KR1veTCAW1vkZslcqSb_MaH5Focb5PrH8va-B1yteA03Q3UYqvlKVK_By-mcYY1nqgdA01YluF31RDcPRQwzomejzRXl1P8q5YOEYdtbqhL0_7Mn5ffF_Qvt5vP717l--5Ghr9oqYOf7pLT7fsvb09Y6bzAvND8gtna20bZ2EJ8IAapXK1b3XqpsZdVUB7kC25dNpoPjuuAvTNC2wzR2yhV5K69Rw7gWfEBoRIxIIWIwUFwKJ3rg0WMMzH4oBWEExWp95IwvsCSY3eMbyalJ700WXgGhGdQeKavyOv5kh8Zk-NvxG9QvDMhwmmnE6BkpiiZ-ZeSVeQpKofJe1Nno2A2Eru0QUQHn_EiUaBZgNf3tuxuACYgwNaK8mhFCdPZr4f3CmiKOZkMhL099uKpZUWezcN4JZbIjXF3mWgUguXXuiL3s77OHw2GG9JMriqiVpq84sp6ZDz_msDGpYaIsJMP_wcbH5EbTZqDDePyiByAosbHENNduCdp-v4CC-ZIkw
  priority: 102
  providerName: Directory of Open Access Journals
– databaseName: Health & Medical Collection
  dbid: 7X7
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1bi9QwFA66gvgi3q2uGkHwAmGbtkmaJxkvwyLoiy7MW8it64K263b3z_hrPSfNdKcI-zIwk9NOm3NPTr5DyKu6rJwTQjGE92aNayzT2gUGqbOrnfcVfGC1xTd5eNR82YhNXnAbc1nl1iYmQx0Gj2vkB-D5W2xHUsr3p38Ydo3C3dXcQuM6uYHQZVjSpTZzwsUVONe8k8lbeTCCLW6x0FIz3kLy1C58UYLs_98w73imZdXkjhta3yG3c_xIVxPD75Jrsb9Hbn7NO-T3yd-d-aZDRy02XB4j9VsIYxpncOOR2j7QhGgZLmuH4O4hQ3KO9KSnU405xQVb2kUctlNbXZpOaZ5d_N6hf7Neff_0drrv0DP8RnM1_PiAHK0___h4yHL_BeaF5ufMlt5WysYaogTRSeVKXevaS40drYLywGVw7rLSvHNcB-ygEeqqi95GqSJ39UOyB_8VHxMqEQlSiBgchIjSuTZYRDoTnQ9aQVBRkHLLCeMzODn2yPhlUpLSSjMxzwDzDDLPtAV5N19yOiFzXEX8Adk7EyKodvphODs2WUeNgGjNV0pBjqma0HCtO91J6ULZCeVjU5AXKBxmOqE6mwazktirDeI6eI3XiQKNAzy-t_mMA0wCwmwtKPcXlKDUfjm8FUCTjcpoLlWgIC_nYbwSC-X6OFwkGoWQ-aUuyKNJXueXBvMNySZXBVELSV7MynKkP_mZIMelhriwkU-ufqyn5FaVtKtiXO6TPRDB-AxitnP3PCnmP3vrQNw
  priority: 102
  providerName: ProQuest
Title Association of adverse childhood experiences and neurodevelopmental disorders in people with fetal alcohol spectrum disorders (FASD) and non-FASD controls
URI https://www.ncbi.nlm.nih.gov/pubmed/31842817
https://www.proquest.com/docview/2328515506
https://www.proquest.com/docview/2327935509
https://pubmed.ncbi.nlm.nih.gov/PMC6912946
https://doaj.org/article/5639c27714474d4199f9f66bd0f57ce4
Volume 19
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3ri9NAEB_uAcd9Ed9Gz7qC4AOiee5mP4i0euUQ7pDTQvHLkn1ED85UmzvQf8W_1plNmjZ4-MEvgXZn02ZnZmc2O_v7ATxJo0TrPBchwXuHmc7KUEptQ1w661Qbk-CFqi1O-NEsez_P51uworfqBrC5cmlHfFKz5fnLnz9-vUGHf-0dvuCvGpxjCyqglGFc4KKo2IZdDEyC_PQ4W28qCIy13cbmld32YQ8tHPNxz162jlIezP_vKXsjZg3rKTcC1PQ6XOsySzZuTeEGbLn6Juwdd3vnt-D3hibYomIlUTE3jpkVuDFzPexxw8raMo91addVRXh324F1NuysZm31OaNXuaxy1Fy2hLvMn99cXn7bkH82HX9897y976IO6RPr6uSb2zCbHn56exR2zAyhyWV8EZaRKRNRuhTzh7ziQkcylanhkriurDCofwz7PJFxpWNpiVvDpknlTOm4cLFO78AO_pa7B4wTRmSeO6sxeeRaF7YkDLS8MlYKTDcCiFaaUKaDLSf2jHPlly8FV60eFepRkR5VEcCLvsv3FrPjX8ITUm8vSHDb_ovF8ovqvFflmMeZRAhcfYrMZrGUlaw41zaqcmFcFsAjMg7Vnl3tJw015sTihhkfPsZTL0GGjH_flN3pBxwEAuAaSB4MJNHdzbB5ZYBq5S0K0-KCuHoiHsDjvpl6Ugld7RaXXkYQmH4kA7jb2mv_0CuzD0AMLHkwKsOW-uyrByPnEjPGjN__754PYD_xPpiEMT-AHbRO9xATvQs9gm0xFyPYnRyefDgd-dclI-_SeD2dfP4Dow1V0Q
linkProvider Scholars Portal
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1bT9RAFJ7gkqgvxrtVlDHRqCQTep3pPBizCJtFYGMUEt7GzqVAol2kEONf8Uf4Gz2nnZZtTHjjZZPdOe1Oe07PpXPm-wh5lYSx1lkmGMJ7s1SnBZNSWwals060MTF8YLfFjE8P0k-H2eES-dvthcG2ys4nNo7azg2-I1-HyJ8jHUnIP5z-ZMgahaurHYVGaxY77vcvKNnq99uboN_XcTzZ2v84ZZ5VgJlMRuesCE0Ri8IlEPuykgsNNb1MDJfI02SFgblDyOKxjEodSYu8EDaJS2cKx4WLdALnvUGW0wRKmRFZ3tiaff7Sr1sICOd-7TTK-XoN3j_H1k7JohzKtXwQ_RqSgP9DwUIsHPZpLgS-yV1yx2esdNya2D2y5Kr75OaeX5N_QP4saJjOS1ogxXPtqOlAk6nr4ZRrWlSWNhia9rJbCc5uPQhoTU8q2na1U3xFTEuHw0VL5EubfaFnFz8W5N9Oxl8337XnnVcMv1Hff18_JAfXoptHZAT_5Z4QyhF7Msuc1ZCUcq1zWyC2WlYaKwWkMQEJO00o4-HQkZXju2rKopyrVnkKlKdQeSoPyFp_yGmLBXKV8AaqtxdEGO_mh_nZkfJeQWWQH5pYCKhqRWrTSMpSlpxrG5aZMC4NyCoah2r3xPbOSI05ssNBJgmX8aaRQHcE0zeF31UBNwGBvQaSKwNJcCNmONwZoPJurFaXD11AXvbDeCS25lVuftHICATpD2VAHrf22l80BAwobyMREDGw5MFdGY5UJ8cNyDmXkImm_OnV01olt6b7e7tqd3u284zcjpsnLWYRXyEjMEf3HDLGc_3CP6aUfLtuz_APWBN-aw
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Association+of+adverse+childhood+experiences+and+neurodevelopmental+disorders+in+people+with+fetal+alcohol+spectrum+disorders+%28FASD%29+and+non-FASD+controls&rft.jtitle=BMC+pediatrics&rft.au=Kambeitz%2C+Cassondra&rft.au=Klug%2C+Marilyn+G.&rft.au=Greenmyer%2C+Jacob&rft.au=Popova%2C+Svetlana&rft.date=2019-12-16&rft.pub=BioMed+Central&rft.eissn=1471-2431&rft.volume=19&rft_id=info:doi/10.1186%2Fs12887-019-1878-8&rft_id=info%3Apmid%2F31842817&rft.externalDocID=PMC6912946
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1471-2431&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1471-2431&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1471-2431&client=summon